Restless Legs Syndrome in Iranian People With Type 2 Diabetes Mellitus: The Role in Quality of Life and Quality of Sleep by Modarresnia, L. et al.
223Journal of Clinical Sleep Medicine, Vol. 14, No. 2 February 15, 2018
Study Objectives: To investigate the prevalence of restless legs syndrome (RLS) in patients with type 2 diabetes mellitus (T2DM) and explore its role in 
quality of life (QoL) and quality of sleep of these patients.
Methods: This is a cross-sectional study performed on 210 Iranian people with T2DM. The diagnosis of RLS was established based on the essential 
diagnostic criteria for RLS recommended by the National Institutes of Health. Sleep quality and QoL were assessed in all participants using Pittsburgh Sleep 
Quality Index and EuroQol five-dimension questionnaire, respectively. Regression models were used for final analysis of data.
Results: The prevalence of RLS was 19.5%; of whom 38.1% had poor quality of sleep. Male sex, being single, body mass index (BMI), and RLS were 
associated with poor quality of sleep. Patients with RLS were almost three times as likely as the patients without RLS to have poor sleep quality. Moreover, 
being female, BMI value, level of glycosylated hemoglobine (HbA1C), and RLS were associated with lower QoL. RLS lowers the score of QoL even more than 
BMI and HbA1C. In addition, the QoL and sleep quality of this population of patients with diabetes have not been affected by the severity of RLS as well as 
presence or absence of neuropathy.
Conclusions: RLS has an independent and significant role in sleep quality and QoL in the patients with diabetes. Neuropathy with RLS does not confer any 
additive burden on QoL and sleep quality of this population of patients with diabetes.
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INTRODUCTION
Restless legs syndrome (RLS) is a circadian sensorimotor dis-
order, manifested by an urge to move the legs, and usually as-
sociated with uncomfortable sensation in the legs.1 The urge 
to move or unpleasant sensation arise or worsen at nights and 
during the episodes of inactivity, and are partially or totally 
relieved by movement.1 RLS is often familial or idiopathic2 but 
may be associated with iron deficiency anemia,3 renal failure,4 
thyroid disorders,5 neuropathy of different causes,6 pregnancy,7 
and type 2 diabetes mellitus (T2DM).8
RLS imposes a significant burden not only on quality of 
sleep and quality of life (QoL)2,9 but also on physical health10 
and health-related costs.9 Sleep-related symptoms are the most 
common and most destructive symptoms experienced by pa-
tients with RLS.11 Sleep is both quantitatively and qualitatively 
impaired by RLS.11 Furthermore, sleep disturbance is respon-
sible for a large proportion of burden of RLS on QoL.9 The 
adverse effects of RLS on QoL are more severe than those 
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imposed by hypertension, recent myocardial infarction, con-
gestive heart failure, angina, diabetes mellitus, and osteoar-
thritis.12 In addition, sleep disturbance, a cardinal feature of 
RLS, has been shown to be a risk factor for impaired glucose 
tolerance,13 insulin resistance, and T2DM.14
However, diabetes, a lifelong disease of increasing preva-
lence, is considerably associated with sleep disturbance and 
subsequently poor glycemic control through different mecha-
nisms.15 RLS, a common comorbidity in patients with diabe-
tes,8,16 can also adversely affect the quality of sleep of these 
patients.16,17 However, this condition is frequently underdiag-
nosed.9 Although identification of sleep abnormalities and their 
effects on QoL in patients with diabetes is the subject of many 
studies, only a few studies looked into RLS and its effect on 
both QoL and quality of sleep of this population. Further un-
derstanding of the link between diabetes and RLS is an im-
portant part of the efforts done to prevent and treat diabetes 
complications. Thus, in this study, we investigated the preva-
lence and severity of RLS in an Iranian population of patients 
BRIEF SUMMARY
Current Knowledge/Study Rationale: Restless legs syndrome (RLS) is a common disorder seen in patients with diabetes. This study aimed to determine 
the prevalence and severity of RSL in a population of patients with diabetes and identify its role in sleep quality and quality of life of these patients.
Study Impact: Having identified the effect of RLS on quality of life and sleep quality of patients with diabetes, we should pay more attention to this 
issue when determining their treatment plan.
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with T2DM and determined the role of RLS in QoL and qual-
ity of sleep in these patients to highlight the burden of this 
neglected but severely disabling disorder.
METHODS
This is a cross-sectional study on patients with T2DM, done 
at a tertiary care center, in Iran, Tehran, in 2016. Patients with 
T2DM, according American Diabetic Association criteria,18 
were selected using the convenience sampling method. The 
sample size including 210 participants was determined apply-
ing the observational study formula.16 Exclusion criteria were 
any known chronic kidney disease (CKD), severe heart dis-
ease, liver disease, active thyroid disorder, obstructive sleep 
apnea (OSA), depression, a history of trauma or hospital ad-
mission during the past 3 months, diabetic duration of less than 
3 months, and age younger than 30 years or older than 70 years. 
An informed written consent was obtained from all the sub-
jects eligible for including in the study.
The diagnosis of RLS was established by a physician based 
on the essential diagnostic criteria for RLS recommended by 
the National Institutes of Health,1 utilizing the validated Per-
sian language version. The criterion excluding RLS mimics 
is not included in the National Institutes of Health criteria; 
however, we excluded RLS mimics (namely, myalgia, venous 
stenosis, leg edema, leg cramp, positional discomfort, habitual 
foot tapping) by an exact physical examination and mimics-
related questions.1 Diabetic neuropathy was documented by 
nerve conduction study. Severity of RLS was evaluated with 
the International RLS Study Group Rating Scale.19 RLS sever-
ity was classified to mild (0–10), moderate (11–20), severe (21–
30), and very severe (31–40) according to total International 
RLS Study Group Rating Scale scores.
Sleep quality was measured in all participants using Pitts-
burgh Sleep Quality Index (PSQI).20,21 Sleep quality, sleep la-
tency, sleep duration, sleep efficiency, sleep disturbance, use 
of sleep medications, and daytime dysfunction were evaluated 
subjectively through 19 self-rating items. Each of the seven 
factors was scored 0 to 3. PSQI total score ranged from 0 to 
21; the higher PSQI global score indicates the poorer quality of 
sleep. PSQI global score higher than 5 has been found to have a 
sensitivity of 98.7% and specificity of 84.4% in differentiating 
good sleepers from poor sleepers.22
QoL was assessed in all participants using EuroQol five-
dimension questionnaire (EQ-5D-3L), a standardized tool for 
measuring general health status.23 This questionnaire consists 
of two components, a health state description part and a visual 
analog scale (VAS).24 Five dimensions of health status, includ-
ing mobility, self-care, usual activities, pain/discomfort, and 
anxiety/depression, are measured in the description part. The 
respondents self-rate the level of severity of each dimension 
using a three-level scale. The VAS indicates health status on 
the day of interview on a 20-cm vertical scale with end points 
of 0 and 100.24 In the EQ-5D-3L, the respondent has to draw a 
line from the box on the questionnaire to the imagined scale.
Weight, height, and blood pressure were measured; another 
questionnaire including demographic information (age, sex, 
occupation, marital status, and smoking status), diabetes-
related variables (including duration of diabetes and type of 
treatment), as well as physician-diagnosed comorbidities (ie, 
hypertension, hyperlipidemia, thyroid disorders, anemia, 
CKD, severe heart disease, liver disease, OSA, depression, and 
hospital admission during the past 3 months) were completed 
by the participants. In addition, in the same session a blood 
sample was obtained for laboratory testing of fasting blood 
sugar, glycated hemoglobin (HbA1C), total cholesterol, low-
density lipoprotein (LDL), high-density lipoprotein (HDL), 
and triglyceride.
All the questionnaires were completed via a face-to-face 
interview between trained physicians and participants. The 
questions that arose during the interview were explained and 
clarified by the investigators. Moreover, if the participants 
were unable to complete the questionnaires, the physicians 
asked them the questions item-by-item orally and recorded the 
answers truthfully.
Statistical Analysis
Data are presented as mean ± standard deviation for continuous 
variables with normal distribution or median and interquartile 
range for non-normally distributed variables. Categorical data 
are presented as frequency and percentage. Analysis of vari-
ance, Mann-Whitney U test, Kruskal-Wallis test, and χ2 test 
were used for comparison of variables between groups. Cor-
relations were evaluated using the Spearman correlation coef-
ficient. After performing the univariate analysis, the variables 
with P < .2 were included in multivariate analysis. For multi-
variate analysis, binary logistic regression model and linear re-
gression analysis were used. A value of P < .05 was considered 
statistically significant. The Statistical Package for Social Sci-
ences (SPSS) version 24 (SPSS Inc., Chicago, Illinois, United 
States) was used for statistical analysis.
RESULTS
Baseline characteristics of all participants are shown in 
Table 1. Two hundred ten patients with T2DM were included 
in the study. The mean age of participants was 54.89 ± 7.81 
years and mean diabetic duration was 7.8 ± 4.89 years. The 
prevalence of RLS was 19.5% (n = 41) in this population of 
patients with diabetes, of whom 21 (51.2%) had evidence of 
neuropathy whereas 20 (48.8%) had no evidence of neuropa-
thy in nerve conduction tests. Based on the International RLS 
Study Group Rating Scale, 29.3%, 51.2%, 14.6%, and 4.9% of 
the patients were affected by mild, moderate, severe, and very 
severe forms of RLS, respectively.
There were 38.1% of all participants and 56.1% of the par-
ticipants with RLS who had poor quality of sleep. Binary 
logistic regression model showed poor quality of sleep is asso-
ciated with male sex (odds ratio [OR] 3.17; 95% CI 1.60–6.29; 
P = .001), being single (OR 3.60; 95% CI 1.04–12.36; P = .04), 
higher body mass index (BMI) level (OR 0.93; 95% CI 0.87–
0.98; P = .014), and the presence of RLS (OR 2.79; 95% CI 
1.30–5.99; P = .008), Table 2. The effect of RLS on sleep qual-
ity was independent of the presence of neuropathy.
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Linear regression analysis for identifying the associated 
factors of poor QoL demonstrated the significant effect of sex 
(male) (coefficient 1.50; P = .001), BMI (coefficient −0.008; 
P = < .001), HbA1C (coefficient −0.015; P = .02), and RLS (coef-
ficient −0.08; P = .007) on QoL (Table 3). In the VAS part of 
the questionnaire, female sex (coefficient −6.04; P = .03), dura-
tion of diabetes (coefficient −0.62; P = .02), BMI (coefficient 
−0.5; P = .02), and being a smoker (coefficient −16.17; P = .003) 
all were associated with an inverse effect on QoL (Table 4). 
Furthermore, patients with poor quality of sleep showed signifi-
cantly lower scores in both parts of the EQ-5D-3L questionnaire 
compared with patients with good quality of sleep (0.80 versus 
0.84, P < .001, in the health state description part; and 60 versus 
70, P < .001, in the VAS part). Finally, our data showed that the 
mobility problem and pain/discomfort aspects of the QoL are 
more affected by RLS. Adverse effect of RLS on QoL in patients 
with neuropathy was the same as those without neuropathy.
DISCUSSION
The prevalence of RLS in this cross-sectional study, carried 
out in a population of Iranian people with T2DM, was 19.5%, 
Table 1—Baseline characteristics of the participants.
Age (years) 54.89 ± 7.81
Diabetic duration (years) 7.8 ± 4.89
SBP (mmHg) 128.65 ± 19.22
DBP (mmHg) 79.83 ± 9.47
FBS (mg/dL) 154.9 ± 66.2
HbA1C (%) 7.84 ± 1.92
TG (mg/dL) 161.74 ± 96.10
Cholesterol (mg/dL) 166.14 ± 43.08
LDL (mg/dL) 92.37 ± 31.55
HDL (mg/dL) 44.27 ± 11.51
QoL (score) 0.82 ± 0.17
VAS (score) 66.24 ± 18.89
Sex Male 83 (39.5)
Female 127 (60.5)






Insulin use Yes 71 (33.8)
No 139 (66.2)
RLS Yes 41 (19.5)
No 169 (80.5)
RLS With neuropathy 21 (51.2)
Without neuropathy 20 (48.8)
PSQI score  ≤ 5 130 (61.9)
 > 5 80 (38.1)
Data are presented as mean ± standard deviation or n (%). DBP = diastolic 
blood pressure, FBS = fasting blood sugar, HbA1C = glycosylated 
hemoglobin, HDL = high density lipoprotein, LDL = low-density 
lipoprotein, PSQI = Pittsburgh Sleep Quality Index, QoL = quality of 
life, RLS = restless legs syndrome, SBP = systolic blood pressure, 
TG = triglyceride, VAS = visual analog scale.
Table 2—Binary logistic regression analysis of factors 
influencing quality of sleep.
Variable OR (95% CI) P
Male 3.176 (1.602–6.293) .001
Single 3.600 (1.049–12.369) .042
BMI 0.930 (0.878–0.986) .014
TG 0.998 (0.995–1.001) .205
RLS 2.793 (1.301–5.998) .008
Multivariate logistic regression analysis, dependent variable is poor 
quality of sleep (PSQI > 5) and covariates are: sex, marital status, 
BMI, TG, and RLS. BMI = body mass index, CI = confidence interval, 
OR = odds ratio, PSQI = Pittsburgh Sleep Quality Index, RLS = restless 
legs syndrome, TG = triglyceride.
Table 3—Linear regression analysis of factors influencing 
QoL.
Variable Coefficient (SE) P
Male 1.508 (0.128) .001
Age (years) −0.083 (0.025) .051
BMI (kg/m2) −0.008 (0.002)  < .001
HbA1C (%) −0.015 (0.006) .021
TG (mg/dL) −0.0001 (0.0001) .345
RLS −0.082 (0.03) .007
Insulin use −0.28 (0.028) .309
Dependent variable is QoL and covariates are: sex, age, BMI, HbA1C, 
TG, RLS, and insulin use. BMI = body mass index, HbA1C = glycosylated 
hemoglobin, QoL = quality of life, RLS = restless legs syndrome, 
SE = standard error, TG = triglyceride.
Table 4—Linear regression analysis of factors influencing 
VAS.
Variable Coefficient (SE) P
Female −6.048 (10.524) .038
Diabetic duration (years) −0.624 (0.269) .021
BMI (kg/m2) −0.558 (0.248) .026
HbA1C (%) −0.744 (0.925) .422
FBS (mg/dL) −0.02 (0.029) .482
Smoker −16.17 (5.442) .003
Insulin use −3.124 (3.170) .326
Dependent variable is VAS and covariates are: sex, diabetic duration, 
BMI, HbA1C, FBS, smoker, and insulin use. BMI = body mass index, 
HbA1C = glycosylated hemoglobin, FBS = fasting blood sugar, 
SE = standard error, VAS = visual analog scale.
226Journal of Clinical Sleep Medicine, Vol. 14, No. 2 February 15, 2018
L Modarresnia, F Golgiri, NH Madani, et al. RLS and Type 2 Diabetes Mellitus
of whom 51.2% also suffered from neuropathy. Patients with 
RLS were more likely to have poor quality of sleep (odds ratio 
2.79; 95% confidence interval 1.30–5.99; P = .008); further-
more, they had a significantly lower QoL score compared to 
patients without RLS (0.83 versus 0.84, P = .009). However, 
there was no significant difference in QoL and sleep quality of 
the participants across the spectrum of RLS severity. Further-
more, RLS in the presence of neuropathy did not confer any 
additional burden on QoL and sleep quality compared to RLS 
without neuropathy.
The prevalence of RLS in our patients with diabetes (19.5%) 
is in line with the results of previous studies. Clinically signifi-
cant RLS, although underdiagnosed,2,9 is common (2.7%) in 
the general population.2 However, the prevalence of any form 
of RLS has been reported to range from 7% to 10%.2,25 More-
over, RLS is over four times more common in patients with 
diabetes than in the general population,8 with a prevalence of 
10% to 42% in different populations with diabetes.26,27
However, 51.2% of patients with RLS had neuropathy docu-
mented by nerve conduction studies. Peripheral neuropathy, 
one of the most common complications of diabetes, can mimic 
symptoms of RLS. Uncomfortable sensations of tingling, 
numbness, burning, and pain all are seen in both conditions, 
making it difficult to distinguish the two disorders.28 However, 
some aspects of history and physical examination, as well as 
the nerve conduction test, can be used to differentiate neuropa-
thy and RLS.28 The fact that not all patients with diabetes and 
RLS suffered from neuropathy supports the results of previ-
ous studies in that neuropathy is not the only leading cause of 
RLS.29
Poor sleep quality was seen in 38.1% of this population 
of patients with diabetes, and was associated with male sex, 
single status, high BMI, and presence of RLS. A large pro-
portion of our patients with diabetes were found to have poor 
sleep quality, consistent with the previous studies in patients 
with diabetes.16 However, the relationship between diabetes 
and sleep disorders is a complex bidirectional relationship.30 
Marriage was a protective factor on quality of sleep among our 
studied population, similar to the results of another study that 
showed an elderly population who had ever married or lived 
with others had a better quality of sleep.31 However, in contrast 
to the results of previous studies,32 we could not find the pro-
tective effect of male sex on quality of sleep. This difference 
may be due to the difference in studied populations because the 
study of Denic-Roberts et al.32 was conducted among an adult 
population with long-standing type 1 diabetes in whom non–
sex-specific prevalence of sleep disturbance did not differ from 
that of the general population. Like other studies, poor quality 
of sleep was also associated with high BMI.33 Moreover, we 
found that patients with RLS were almost three times as likely 
as those without RLS to have poor quality of sleep. This find-
ing strongly supports the results of previous studies regarding 
the role of RLS in sleep disturbance.17 Nevertheless, we found 
no association between some other variables, such as age, dia-
betic duration, smoking status, blood pressure, fasting blood 
sugar, HbA1C, total cholesterol, triglyceride, HDL, LDL, and 
poor quality of sleep. However, previous studies in this respect 
yielded conflicting results.34–36 These controversies may be due 
to the difference in studied populations and applied methods. 
Moreover, there is a complex interrelationship between these 
demographic and clinical variables and sleep-related compo-
nents that requires more comprehensive investigations for bet-
ter understanding.
We also explored the QoL of our participants through 
EQ-5D-3L questionnaire. Advanced age, high BMI values, 
high HbA1C level, and being female were associated with 
lower QoL. Moreover, RLS lowers the score of QoL by 0.08. 
Considering the VAS part of the questionnaire, which indicates 
health status on the day of interview, we found lower scores for 
females, smokers, and patients with longer duration of diabetes 
and higher BMI. Furthermore, the mobility problem and pain/
discomfort dimensions of the questionnaire were more affected 
by the presence of RLS. Patients with diabetes are known to 
have worse QoL than individuals without diabetes.37 Our study 
supports the results of previous studies regarding the fact that 
being female,38 advanced age,39 higher BMI,39 and poorer gly-
cemic control40 all are associated with lower QoL in patients 
with diabetes. In addition, we did not find any negative effect 
of duration of diabetes and insulin use on QoL, like some other 
studies.41,42 However, some controversies still exist about these 
findings.39,43,44 These controversies may be due to the influence 
of several factors such as the existence of other health prob-
lems, the presence of diabetes-related complications, living 
status (with family or alone), social relationship, and the level 
of education that obviously are not considered in all studies 
and may confound the results. Among the factors that affect 
QoL of patients with diabetes, RLS is more consistently as-
sociated with low QoL.2,12,45 It can adversely affect both physi-
cal and mental aspects of QoL.10,45 A study by Kushida et al. 
showed that RLS is associated with a unique burden on both 
mental and physical aspects of QoL in the general population, 
and this burden is even greater than that imposed by T2DM.10 
Moreover, our study showed that RLS lowers QoL of the pa-
tients with diabetes, even more than obesity and high HbA1C 
level. Thus, physicians should pay as much attention on the 
evaluation and treatment of RLS as they do on the other predic-
tors of poor QoL in patients with diabetes.
In addition, both RLS and neuropathy can interfere with 
sleep.28 Furthermore, it is well established that RLS and neu-
ropathy are independent predictors of poor QoL in patients with 
diabetes.45,46 Our study showed that although RLS impairs QoL 
of patients with diabetes, neuropathic RLS does not confer ad-
ditive burden on QoL compared to RLS without neuropathy.
To our knowledge, this was the first study that addressed the 
prevalence and severity of RLS in Iranian people with T2DM 
and examined the role of RLS across the spectrum of its sever-
ity on both QoL and sleep quality of these patients. Another 
new aspect of our study is that we compared the effect of RLS 
with and without neuropathy on QoL and sleep quality of pa-
tients with diabetes. Furthermore, we excluded some other dis-
eases such as CKD, OSA, and thyroid disorders that have the 
potential to affect the QoL of patients with diabetes.
However, the interpretation of the results has some limita-
tions. First, because it is a cross-sectional study, determina-
tion of causality cannot be established. Second, evaluation of 
sleep was subjective and self-reported. Obviously objective 
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measures (eg, polysomnography) would offer more valid re-
sults. And finally, there were a few confounders that were not 
adjusted, such as diabetic-related complications other than 
CKD, some other comorbidities, socioeconomic factors, and 
education level that may have an important role in quality of 
sleep and QoL.
In conclusion, the prevalence of RLS in this population of 
Iranians with T2DM was 19.5%. A large portion of this popu-
lation (51.2%) had a moderate form of RLS whereas a small 
number of them (4.9%) showed a very severe form of this disor-
der. Poor sleep quality was associated with being male, single 
status, high BMI, and the presence of RLS. Patients with RLS 
were almost three times as likely as those without RLS to have 
poor quality of sleep. In addition, poor QoL in this population 
of patients with diabetes was associated with being female, 
high level of HbA1C, high BMI, and presence of RLS. RLS 
lowers QoL score even more than HbA1C and BMI. Moreover, 
RLS affects the mobility problem and pain/discomfort aspects 
of QoL. Furthermore, RLS impairs the QoL and sleep quality 
of this population of patients with diabetes independently of 
the presence of neuropathy.
ABBRE VI ATIONS
BMI, body mass index
CKD, chronic kidney disease
EQ-5D-3L, EuroQol five-dimension questionnaire




PSQI, Pittsburgh Sleep Quality Index
QoL, quality of life
RLS, restless legs syndrome
T2DM, type 2 diabetes mellitus
TG, triglyceride
VAS, visual analog scale
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